CHM
Click for more information
0.00% 1.4¢ chimeric therapeutics limited

Chimeric: Media Thread, page-545

  1. dalts66
    4,361 Posts.
    lightbulb Created with Sketch. 2034
    clock Created with Sketch.
    28/11/23
    08:45
    Post #: 71137507
    https://endpts.com/marks-fda-open-to-using-single-arm-studies-for-accelerated-approval-of-rare-disease-gene-therapies/

    The FDA being patient focused and flexible for accelerated approvals.
    CHM Price at posting: 2.8¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RDN Preliminary interpretation of Andover South reveals key NE-trending corridor hosting lithium mineralization
right-arrow Created with Sketch.
NEWS Uncover the potential at the Storm Project, where exceptional RC drill results reveal 22.9m at 8.5% Cu, indicating significant resource expansion beyond the Cyclone Deposit
right-arrow Created with Sketch.
NEWS High-grade manganese found at the W2 prospect in Wandanya
right-arrow Created with Sketch.
NEWS Discover how gas production wells are progressing with successful drilling and promising early gas flows
right-arrow Created with Sketch.
NEWS New drilling at the Rogozna Project delivers a standout intercept, highlighting significant resource expansion potential
right-arrow Created with Sketch.
NEWS $140,000 in grant funding has been secured for drilling at Golden Ridge, with preparations underway for two exciting prospects
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.4¢ 		Change
0.000(0.00%) 		Mkt cap ! $12.67M
Open High Low Value Volume
1.5¢ 1.5¢ 1.4¢ $15.87K 1.103M

Buyers (Bids)

No. Vol. Price($)
2 1876837 1.4¢
 

Sellers (Offers)

Price($) Vol. No.
1.5¢ 96056 2
View Market Depth
Last trade - 16.10pm 27/09/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.